Affiliation:
1. People's Hospital, Fujian University of Traditional Chinese Medicine
2. College of Rehabilitation Medicine, Fujian University of Traditional Chinese Medicine
3. Fuzong Clinical Medical College, Fujian Medical University
4. Xiamen Hospital, Beijing University of Chinese Medicine
Abstract
Abstract
Introduction: Tumor size constitutes a very important staging factor among patients afflicted by solid tumors, and was closely associated with the overall survival (OS). Nonetheless, the prognostic import of tumor size in gastric cancer (GC) remains shrouded in uncertainty.
Method: A multivariable-adjusted hazard ratio (HR) along with a 95% confidence interval (CI) was computed for GC using Cox proportional hazard regression models. To assess the non-linear association between tumor size and OS, we employed a restricted cubic spline regression analysis. Additionally, a two-piece-wise Cox proportional hazard model was utilized to determine the threshold effect. The efficacy prediction of tumor size was tested by ROC curve.
Results: A cohort comprising 2,012 gastric cancer patients who had undergone gastrectomy was included in our secondary analysis, sourced from a multicenter study conducted in Korea. Also, we found a nonlinear association between tumor size and OS at the turning point as 5.7 (95%CI: 5.1, 6.8). The HR for mortality was 1.50 (95%CI: 1.38, 1.64) for tumors size <5.7, while 1.09 (95%CI: 1.05, 1.13) with size ≥ 5.7. There was still a significant non-linear relationship between OS and size after adjusting for potential confounding factors (P=0.001). In addition, Besides, a significantly higher HR was found in young GC patients(≤45: 1.33; 95%CI:1.24, 1.41; >45, 1.16; 95%CI: 1.13,1.19; P for interaction = 0.0004 ).
Conclusions: Tumor size was non-linear associated with survival for patients receiving gastrectomy. It might have the higher predictive power in young GC.
Publisher
Research Square Platform LLC
Reference16 articles.
1. Current treatment and recent progress in gastric cancer[J];Joshi SS;CA Cancer J Clin,2021
2. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J];Xia C;Chin Med J (Engl),2022
3. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies[J];Machlowska J;Int J Mol Sci,2020
4. Gastric cancer: a comprehensive review of current and future treatment strategies[J];Sexton RE;Cancer Metastasis Rev,2020
5. Association JGC. Japanese gastric cancer treatment guidelines 2018 (5th edition)[J]. Gastric Cancer, 2021,24(1):1–21.